Nicotinamide adenine dinucleotide suppresses epileptogenesis at an early stage

The pathophysiologic mechanisms of epileptogenesis are poorly understood, and no effective therapy exists for suppressing epileptogenesis. Numerous reports have shown that nicotinamide adenine dinucleotide (NAD(+)) has neuroprotective effects, suggesting its potential use for treating epileptogenesi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Juan, Yang, Beimeng, Zhou, Pei, Kong, Yingying, Hu, Weiwei, Zhu, Geng, Ying, Weihai, Li, Weidong, Wang, Yun, Li, Shengtian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544671/
https://www.ncbi.nlm.nih.gov/pubmed/28779137
http://dx.doi.org/10.1038/s41598-017-07343-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544671/
https://www.ncbi.nlm.nih.gov/pubmed/28779137
http://dx.doi.org/10.1038/s41598-017-07343-0

Ejemplares similares